secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2024-03-14T23:59:59+00:00
Accession:  0001193125-24-068002
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Plus Therapeutics receives Nasdaq delisting notice for equity deficiency
------------------------------------------------------------------------

- Stockholders' equity was ($1,348,000) as of Dec 31, 2023, below Nasdaq's $2.5M minimum.
- Company has 45 days (until Apr 22, 2024) to submit a plan to regain compliance.
- If accepted, Nasdaq may grant up to 180 days (until Sep 4, 2024) to cure the deficiency.
- Company plans to pursue capital raising to satisfy the equity or alternative standards.
- Failure to regain compliance could result in delisting of PSTV common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000119312524068002/0001193125-24-068002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000119312524068002/d794768d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-068002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer